CompanyGraph
Guangzhou LBP Medicine Science & Technology Co., Ltd.
688393 · SSE · China
gzlbp.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $31.26M, above the global median of $18.92M
- PositionDebt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.45%Below 5Y avg (0.75%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
750.0%High
Last Ex-Dividend
Jun 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.09BCNY312.58M · vs all stocks (USD)
Revenue (TTM)
356.56MCNY53.22M · vs all stocks (USD)
Profit Margin
-9.47%vs Medical Instruments & Supplies peers
Beta
0.4870xvs all stocks
52-Week Change
-15.61%vs all stocks
Market Capitalization
2.09BCNY312.58M · vs all stocks (USD)
Enterprise Value
1.81BCNY269.49M · vs all stocks (USD)
Price to Sales (TTM)
5.87xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.21xvs Medical Instruments & Supplies peers
Enterprise to Revenue
5.06xvs Medical Instruments & Supplies peers
Gross Margin
64.82%vs Medical Instruments & Supplies peers
Profit Margin
-9.47%vs Medical Instruments & Supplies peers
Operating Margin
0.56%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-2.36%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-3.12%vs Medical Instruments & Supplies peers
Revenue (TTM)
356.56MCNY53.22M · vs all stocks (USD)
Revenue per Share (TTM)
4.23CNYUpdated Sep 22, 2026Quarterly Revenue Growth
5.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
224.07MCNY33.45M · vs all stocks (USD)
EBITDA (TTM)
6.44MCNY961.75K · vs all stocks (USD)
Net Income (TTM)
-33.76MCNY-5.04M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
26.77%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
24.30MCNY3.63M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
209.39MCNY31.26M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.45%vs all stocks
5-Year Average Dividend Yield
0.75%vs all stocks
Payout Ratio
750.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
-24.53MCNYFY2025 · Dec 31, 2025Revenue
344.45MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
125.22MCNYFY2025 · Dec 31, 2025Gross Profit
219.22MCNYFY2025 · Dec 31, 2025Operating Income
-54.58MCNY-8.15M · vs all stocks (USD)
Pre-tax Income
-55.16MCNYFY2025 · Dec 31, 2025Income Tax Expense
-4.36MCNYFY2025 · Dec 31, 2025Net Income
-50.80MCNYFY2025 · Dec 31, 2025EBIT
-54.84MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.44MCNYFY2025 · Dec 31, 2025Research & Development
36.06MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
93.31MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.79MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
327.03KCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.5000CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.5000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
94.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
94.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-50.80MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.78MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-1.88MCNYFY2025 · Dec 31, 2025Free Cash Flow
-25.03MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
31.26MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-50.80MCNYFY2025 · Dec 31, 2025Other Non-cash Items
4.78MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
69.18MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-25.04MCNYFY2025 · Dec 31, 2025Capital Expenditures
-23.15MCNYFY2025 · Dec 31, 2025Net Acquisitions
-7.13MCNYFY2025 · Dec 31, 2025Purchase of Investments
-786.75MCNYFY2025 · Dec 31, 2025Sale of Investments
742.44MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-74.58MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
150.00KCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-7.30MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-9.53MCNYFY2025 · Dec 31, 2025Other Financing Charges
-9.14MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-25.82MCNYFY2025 · Dec 31, 2025Shares Outstanding
93.57MSharesUpdated Sep 22, 2026Float Shares
55.12MSharesUpdated Sep 22, 2026% Held by Insiders
48.40%vs all stocks
% Held by Institutions
6.82%vs all stocks
Total Cash (MRQ)
287.48MCNY42.91M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.07CNYUpdated Sep 22, 2026Total Debt (MRQ)
2.53MCNY378.34K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0022xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
8.18xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
18.57CNYUpdated Sep 22, 2026Total Assets
1.29BCNY192.17M · vs all stocks (USD)
Total Current Assets
612.13MCNYFY2025 · Dec 31, 2025Total Liabilities
127.98MCNYFY2025 · Dec 31, 2025Total Non-current Assets
675.28MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
44.61MCNYFY2025 · Dec 31, 2025Total Current Liabilities
83.37MCNYFY2025 · Dec 31, 2025Cash
31.18MCNYFY2025 · Dec 31, 2025Cash Equivalents
89.67KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
31.27MCNYFY2025 · Dec 31, 2025Other Short-term Investments
234.36MCNYFY2025 · Dec 31, 2025Accounts Receivable
176.82MCNYFY2025 · Dec 31, 2025Inventory
90.12MCNYFY2025 · Dec 31, 2025Accounts Payable
33.73MCNYFY2025 · Dec 31, 2025Short-term Debt
2.22MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.04MCNYFY2025 · Dec 31, 2025Long-term Debt
879.45KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.65MCNYFY2025 · Dec 31, 2025Common Stock (Book)
93.57MCNYFY2025 · Dec 31, 2025Retained Earnings
324.99MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.16BCNY173.07M · vs all stocks (USD)
52-Week Low
15.70CNYUpdated Sep 22, 202652-Week High
38.96CNYUpdated Sep 22, 202652-Week Change
-15.61%vs all stocks
Beta
0.4870xvs all stocks
50-Day MA
19.21CNYUpdated Sep 22, 2026200-Day MA
23.01CNYUpdated Sep 22, 2026Avg 10-Day Volume
2.11MSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.95MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.3600CNYUpdated Sep 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
Where is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 59.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.65Profit Margin: -0.09
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.60
Altman Z-Score 10.79: safe zoneNotable
Altman Z-Score: 10.79
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $31.26M, above the global median of $18.92MNotable
Levered free cash flow (USD): 31,255,599.922Global Median: 18,920,810.7
Companies that share the same coordination system — how they create, deliver, or capture value.
Fsp Technology Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Anhui Huaqi Environmental Protection Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jindal Poly Films Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Giken Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Bescient Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
A&D Holon Holdings Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Moreld ASA
Tier 1ProductionThroughput-Bound ConversionFlowRule
Boen Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinomach General Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
National Company for Glass Industries
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Nanjing Xinjiekou Department Store Co. Ltd.
2 interpretationsDown-Close Share With Multi-Year Earnings DecreaseMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Heron Neutron Medical Corp.
2 interpretationsDown-Close Share With Multi-Year Earnings DecreaseMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Greenland Holdings Corporation Limited
1 interpretationDown-Close Share With Multi-Year Earnings Decrease